Shunts vs endoscopic third ventriculostomy in infants: are there different types and/or rates of complications? A review.
BACKGROUND
The decision-making process when we compare endoscopic third ventriculostomy (ETV) with shunts as surgical options for the treatment of hydrocephalus in infants is conditioned by the incidence of specific and shared complications of the two surgical procedures.


METHODS
Our literature review shows that the advantages of ETV in terms of complications are almost all related to two factors: (a) the avoidance of a foreign body implantation and (b) the establishment of a 'physiological' cerebrospinal fluid (CSF) circulation. Both these kinds of achievements are particularly important in infants because of the relative high rate of some intraoperative (i.e. abdominal) and late (secondary craniosynostosis, slit-ventricle syndrome) shunt complications in this specific subset of patients. On the other side, the main factor which is claimed against ETV is the relatively high risk of immediate mortality and neurological complications. Clinical manifestations of neurological structure damage seem to be more frequent in infants, probably due to the more relevant effect of parenchymal and vascular damage in this age group; however, both the immediate mortality and neurological damage risk of ETV procedures should be weighted against the long-term mortality and the late neurological damage which is not infrequently described as a consequence of shunt malfunction and proximal shunt revision procedures. Infections are possible in both ETV and extrathecal CSF procedures, especially in infants. However, the incidence of infective complications is significantly lower in case of ETV (1-5% vs 1-20%). Moreover, different from shunting procedures, infections in children with third ventriculostomy have a more benign course, being generally controlled by antibiotic treatment alone.
Di Rocco
C
C
Pediatric Neurosurgical Unit, Catholic University, Largo A. Gemelli, Rome, Italy. cdirocco@rm.unicatt.it
Massimi
L
L
Tamburrini
G
G
D002557:Cerebrospinal Fluid Shunts / Q000009:adverse effects*; D004724:Endoscopy / Q000009:adverse effects*; D006801:Humans; D006849:Hydrocephalus / Q000601:surgery*; D007223:Infant; D011183:Postoperative Complications; D020542:Third Ventricle / Q000601:surgery*; D014696:Ventriculostomy / Q000009:adverse effects* / Q000379:methods